Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP257655.RASHUaSHmtc2sTtW1j6sI_zSnbJT9nO0_brs5ir7-uaR8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP257655.RASHUaSHmtc2sTtW1j6sI_zSnbJT9nO0_brs5ir7-uaR8130_assertion type Assertion NP257655.RASHUaSHmtc2sTtW1j6sI_zSnbJT9nO0_brs5ir7-uaR8130_head.
- NP257655.RASHUaSHmtc2sTtW1j6sI_zSnbJT9nO0_brs5ir7-uaR8130_assertion description "[The purpose is to study the prognostic significance of tissue expression of trypsinogen-1, trypsinogen-2, and tumor-associated trypsin inhibitor (TATI) and serum concentration of trypsinogen-2, trypsin-2-API (complex of trypsin-2 with alpha-1-proteinase inhibitor), and TATI in epithelial ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP257655.RASHUaSHmtc2sTtW1j6sI_zSnbJT9nO0_brs5ir7-uaR8130_provenance.
- NP257655.RASHUaSHmtc2sTtW1j6sI_zSnbJT9nO0_brs5ir7-uaR8130_assertion evidence source_evidence_literature NP257655.RASHUaSHmtc2sTtW1j6sI_zSnbJT9nO0_brs5ir7-uaR8130_provenance.
- NP257655.RASHUaSHmtc2sTtW1j6sI_zSnbJT9nO0_brs5ir7-uaR8130_assertion SIO_000772 15269150 NP257655.RASHUaSHmtc2sTtW1j6sI_zSnbJT9nO0_brs5ir7-uaR8130_provenance.
- NP257655.RASHUaSHmtc2sTtW1j6sI_zSnbJT9nO0_brs5ir7-uaR8130_assertion wasDerivedFrom befree-20140225 NP257655.RASHUaSHmtc2sTtW1j6sI_zSnbJT9nO0_brs5ir7-uaR8130_provenance.
- NP257655.RASHUaSHmtc2sTtW1j6sI_zSnbJT9nO0_brs5ir7-uaR8130_assertion wasGeneratedBy ECO_0000203 NP257655.RASHUaSHmtc2sTtW1j6sI_zSnbJT9nO0_brs5ir7-uaR8130_provenance.